1. Home
  2. SONN vs DGLY Comparison

SONN vs DGLY Comparison

Compare SONN & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • DGLY
  • Stock Information
  • Founded
  • SONN N/A
  • DGLY 2004
  • Country
  • SONN United States
  • DGLY United States
  • Employees
  • SONN N/A
  • DGLY N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • SONN Health Care
  • DGLY Technology
  • Exchange
  • SONN Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • SONN 3.8M
  • DGLY 3.9M
  • IPO Year
  • SONN N/A
  • DGLY N/A
  • Fundamental
  • Price
  • SONN $3.99
  • DGLY $2.04
  • Analyst Decision
  • SONN Strong Buy
  • DGLY
  • Analyst Count
  • SONN 1
  • DGLY 0
  • Target Price
  • SONN $20.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • SONN 11.6M
  • DGLY 87.5K
  • Earning Date
  • SONN 08-13-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • SONN N/A
  • DGLY N/A
  • EPS Growth
  • SONN N/A
  • DGLY N/A
  • EPS
  • SONN N/A
  • DGLY N/A
  • Revenue
  • SONN $1,000,000.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • SONN $5,376.22
  • DGLY N/A
  • Revenue Next Year
  • SONN N/A
  • DGLY N/A
  • P/E Ratio
  • SONN N/A
  • DGLY N/A
  • Revenue Growth
  • SONN 978.39
  • DGLY N/A
  • 52 Week Low
  • SONN $1.08
  • DGLY $1.91
  • 52 Week High
  • SONN $19.30
  • DGLY $217.00
  • Technical
  • Relative Strength Index (RSI)
  • SONN 47.24
  • DGLY 26.58
  • Support Level
  • SONN $4.16
  • DGLY $1.91
  • Resistance Level
  • SONN $19.30
  • DGLY $2.11
  • Average True Range (ATR)
  • SONN 1.98
  • DGLY 0.12
  • MACD
  • SONN -0.41
  • DGLY 0.49
  • Stochastic Oscillator
  • SONN 1.03
  • DGLY 31.71

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: